Human immunoglobulin constant heavy G chain (IGHG) (Fcγ) (GM) genes, defining innate variants of IgG molecules and B cells, have impact on disease and therapy

Clinical Immunology

Volumn 149, Issue 3 PB, 2013, Pages 475-486

  Oxelius, Vivi Anne ^a   Pandey, Janardan P ^b  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Active and passive immunotherapies; ; IgG related diseases; ; IGHG (Fc ) (GM) genes; ; Innate IgG molecules and B cells;

Indexed keywords

CETUXIMAB; HAEMOPHILUS INFLUENZAE TYPE B VACCINE; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2; IMMUNOGLOBULIN G3; IMMUNOGLOBULIN G4; MUCIN 1; POLYSACCHARIDE VACCINE; TRASTUZUMAB;

ACTIVE IMMUNIZATION; ALLERGIC ASTHMA; ALLERGY; ALLOGENEIC STEM CELL TRANSPLANTATION; ALLOTYPE; ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; ANTIBODY PRODUCTION; ANTIGEN BINDING; ASTHMA; AUTOIMMUNITY; AUTOLOGOUS STEM CELL TRANSPLANTATION; B LYMPHOCYTE; BACTERIAL INFECTION; CANCER CELL; CANCER PATIENT; CANCER PROGNOSIS; CAUCASIAN; CHRONIC BRONCHITIS; COLORECTAL CANCER; COMMON VARIABLE IMMUNODEFICIENCY; DRUG MECHANISM; DRUG RESISTANCE; ECZEMA; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENE MAPPING; GENE MUTATION; GENETIC ASSOCIATION; GENETIC RESISTANCE; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HAEMOPHILUS INFECTION; HAEMOPHILUS INFLUENZAE; HAEMOPHILUS INFLUENZAE TYPE B; HALF LIFE TIME; HAPLOTYPE; HAPLOTYPE MAP; HAY FEVER; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN CYTOMEGALOVIRUS; HUMAN IMMUNODEFICIENCY VIRUS; IMMUNE DEFICIENCY; IMMUNODIFFUSION; IMMUNOGLOBULIN G DEFICIENCY; IMMUNOGLOBULIN GENE; IMMUNOGLOBULIN HEAVY CHAIN GENE; IMMUNOSURVEILLANCE; IMMUNOTHERAPY; LUNG NON SMALL CELL CANCER; MORAXELLACEAE INFECTION; NEWBORN SEPSIS; PHENOTYPE; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; REVIEW; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS GROUP A; SURINAME; TYPHOID FEVER; VIRAL CLEARANCE; WISKOTT ALDRICH SYNDROME; YELLOW FEVER;

EID: 84887564125     PISSN: 15216616     EISSN: 15217035     Source Type: Journal    
DOI: 10.1016/j.clim.2013.10.003     Document Type: Review

References (41)

1. Grubb R. Agglutination of erythrocytes coated with "incomplete" anti-Rh by certain rheumatoid arthritic sera and some other sera. The existence of human serum groups. Acta path. Microb. Scand. 1956, 39:195-197.
2. Grubb R. The Genetic Markers of Human Immunoglobulins 1970, Springer-Verlag, Berlin.
3. Grubb R. Human immunoglobulin allotypes and Mendelian polymorphism of the human immunoglobulin genes. Immunochemistry New York 1994, 47-68. Marcel Dekker. C.J. Oss, M.H.V. Regenmorte (Eds.).
4. Oxelius V.-A., Carlsson A.-M. Quantitation of Gm allotypes. Scand. J. Immunol. 1993, 37:143-148.
5. Oxelius V.-A. Preparation of IgG subclass allotypes from polyclonal IgG. Scand. J. Immunol. 1999, 49:395-398.
6. Pandey J.P. Genetic polymorphism of Fc. Science 2006, 311:1376-1377.
7. Pandey J.P. Genomevide association studies and assessment of risk of disease. N. Engl. J. Med. 2010, 363:2076-2077.
8. Pandey J.P. Candidate gene approach's missing link. Science 2010, 329:1148.
9. Oxelius V.-A., Aurivillius M., Carlsson A.-M., Musi K. Serum Gm allotype development during childhood. Scand. J. Immunol. 1999, 50:440-446.
10. Oxelius V.-A. Genetic B cell variation based on ImmunoGlobulin Heavy G chain (Gm) genes. Scand. J. Immunol. 1999, 49:345-346.
11. Rautonen N., Seppälä I., Hallberg T., Grubb R., Mäkälä O. Determination of homozygosity for the G2m(n) allotype by a monoclonal precipitating antibody. Exp. Clin. Immunogenet. 1989, 6:31-37.
12. Granoff D.M., Holmes S. G2m(23) immunoglobulin allotype and immunity to Haemophilus influenzae type b. J. Infect. Dis. 1992, 65(Suppl. 1):S66-S69.
13. Oxelius V.-A., Eibl M.M. Different Gm allotype levels in human intravenous immunoglobulin (IVIG) preparations, survival of foreign Gm allotypes in immunodeficient patients. Clin. Exp. Immunol. 1996, 106:203-207.
14. Oxelius V.A. Lack of G2m (n) allotype in IgG subclass deficiency in IgG2 deficiency together with lack of G1m(a) and G3m(g) and in IgG3 deficiency together with lack of G1m(f) and G3m(b). Scand. J. Immunol. 1990, 31:293-298.
15. de Vries R.R., Meera Khan P., Bernini L.F., van Loghem E., Van Rood J.J. Genetic control of survival in epidemics. J. Immunogenet. 1979, 6:271-287.
16. Oxelius V.-A., Lindén V., Kvist-Christensen K., Christensen P. Deficiency of IgG subclasses in mothers of infants with Group B streptococcal septicaemia. Int. Archaeol. Allergy Appl. Immun. 1983, 72:249-252.
17. Pandey J.P., Fudenberg H.H., Virella G., Kyong C.U., Loadholt C.B., Galbraith R.M., Gotschlich E.C., Parke J.C. Association between immunoglobulin allotypes and immune responses to Haemophilus influenzae and meningococcus polysaccharides. Lancet 1979, i:190-192.
18. Ambrosino D.M., Schiffman G., Gotschlich E.C., Schur P.H., Rosenberg G.A., de Lange G.G., van Loghem E., Siber G.R. Correlation between G2m(n) immunoglobulin allotype and human antibody response and susceptibility to polysaccharide encapsulated bacteria. J. Clin. Invest. 1985, 75:1935-1942.
19. Carson R.T., McDonald D.F., Kehoe M.A., Calvert J.E. Influence of Gm allotype on the IgG subclass response to streptococcal M protein and outer membrane protein of Moraxella catarrhalis. Immunology 1994, 83:107-113.
20. Goldblatt D., Scadding G.K., Lund V.J., Wade A.M., Turner M.W., Pandey J.P. Association of Gm allotypes with antibody response to the outer membrane protein of a common upper respiratory tract organism, Moraxella catarrhalis. J. Immunol. 1994, 153:5316-5320.
21. Atherton A., Armour K.L., Bell S., Minson A.C., Clark M.R. The herpes simplex virus type 1 Fc receptor discriminate between IgG1 allotypes. Eur. J. Immunol. 2000, 30:2540-2547.
22. Frank I., Friedman H.M. A novel function of the herpes simplex virus type 1 Fc receptor: participation in bipolar bridging of antiviral immunoglobulin G. J. Virol. 1989, 63:4479-4488.
23. Dubin G., Socolof E., Frank I., Friedman H.M. Herpes simplex virus type 1 Fc receptor protects infected cells from antibody-dependent cellular cytotoxicity. J. Virol. 1991, 65:7046-7050.
24. Namboodiri A.M., Budkowska A., Nietert P.J., Pandey J.P. Fcγ receptor-like hepatitis C virus core protein binds differentially to IgG of discordant Fc (GM) genotypes. Mol. Immunol. 2007, 44:3805-3808.
25. Sprague E.R., Wang C., Baker D., Bjorkman P.J. Crystal structure of the HCV-1 Fc receptor bound to Fc reveals a mechanism for bipolar bridging. PLoS Biol. 2006, 4:e:148.
26. Namboodiri A.M., Pandey J.P. The human cytomegalovirus TRLII/IRLII encoded FcγR binds differently to allelic variants of immunoglobulin G1. Arch. Virol. 2011, 156:967-970.
27. Deepe R.N., Kistner-Griffin E., Martin J.N., Deeks Sg., Pandey J.P. Epistatic interactions between Fc (GM) and FcγR genes and the host control of human immunodeficiency virus replication. Hum. Immunol. 2012, 73:263-266.
28. Aurivillius M., Oymar K., Oxelius V.-A. Immunoglobulin heavy G2 chain (IGHG2) gene restriction in the development of severe respiratory syncytial virus infection. Acta Paediatr. 2005, 94:414-418.
29. Morell A., Vasalli G., de Lange G.G., Skvaril F., Ambrosino D.M., Siber G.R. Ig allotype-linked regulation of class and subclass composition of natural antibodies to group A streptococcal carbohydrate. J. Immunol. 1989, 142:2495-2500.
30. Hahn-Zoric M., Ulanova M., Friman V., Björkander J., Oxelius V.-A., Lucas A., Hanson L.A. Antibody response to the Haemophilus influenzae type b-tetanus toxoid conjugate vaccine in healthy and infection-prone individuals with IgG3 subclass deficiency. J. Clin. Immunol. 2004, 24(5):561-570.
31. Jefferis R., Lefranc M.P. Human immunoglobulin allotypes: possible implications for immunogenicity. MAbs 2009, 1:332-338.
32. Namboodiri A.M., Pandey J.P. Differential inhibition of trastuzumab- and cetuximab-induced cyrotoxicity of cancer cells by immunoglobulin G1 expressing different GM allotypes. Clin. Exp. Immunol. 2011, 166(3):361-365.
33. Oxelius V.-A., Ochs H., Hammarström L. Restricted immunoglobulin heavy G chain genes in primary immunodeficiencies. Clin. Immunol. 2008, 128:190-198.
34. Oxelius V.-A. Immunoglobulin constant heavy G subclass genes in asthma and allergy. Immunol. Res. 2008, 40:179-191.
35. Oxelius V.-A., Bråbäck L., Ahlstedt S., Björksten B. Immunoglobulin constant heavy G chain genes as risk factors in childhood allergies. Clin. Exp. Allergy 2006, 36:1616-1624.
36. Oxelius V.-A. From genotypes of immunoglobulin constant heavy G chains, IGHG (Fcγ) (GM) genes to phenotypes in childhood asthma. Int. Arch. Allergy Immunol. 2012, 159:94-102.
37. Gustafsson P.M., Oxelius V.-A., Nilsson S., Kjellman B. Association between Gm allotypes and asthma severity from childhood to young middle age. Respir. Med. 2008, 102:266-272.
38. Oxelius V.-A., Svantesson H., Carlsson A.-M. GM phenotype linkage to subsets of juvenile chronic arthritis (JCA). Scand. J. Rheum. 1993, 22:284-288.
39. Jönsson G., Oxelius V.-A., Truedsson L., Braconier J.H., Sturfelt G., Sjöholm A.G. Homozygosity for the IgG2 subclass allotype G2M(n) protects against severe infections in hereditary C2 deficiency. J. Immunol. 2006, 177(1):722-728.
40. Pandey J.P., Nietert P.J., Klaamas K., Kurtenkov O. A genetic variant of immunoglobulin gamma2 is strongly associated with immunity to mucin 1 in patients with breast cancer. Cancer Immunol. Immunother. 2009, 58:2025-2029.
41. Nakao Y., Matsumoto H., Miyazaki T., Watanabe S., Mukojima T., Kawashima R., Fujita T., Tsuji K. Immunoglobulin G heavy chain allotypes as possible genetic markers for human cancer. J. Natl. Cancer Inst. 1981, 67:47-50.